tiprankstipranks
CSL Limited Reports Cessation of Securities
PremiumCompany AnnouncementsCSL Limited Reports Cessation of Securities
4M ago
Australian Stocks: CSL Shares Retain “Strong Buy” Rating from Analysts
PremiumGlobal Markets
Australian Stocks: CSL Shares Retain “Strong Buy” Rating from Analysts
4M ago
CSL Share Price Decline Continues, Here’s Why
PremiumGlobal Markets
CSL Share Price Decline Continues, Here’s Why
5M ago
CSL: An ASX “Strong Buy” Value Pick for 2024 
PremiumGlobal MarketsCSL: An ASX “Strong Buy” Value Pick for 2024 
7M ago
Arcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity
PremiumThe Fly
Arcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity
7M ago
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
PremiumThe Fly
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
7M ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe FlyJefferies healthcare analyst holds an analyst/industry conference call
12M ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
12M ago
CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
PremiumThe Fly
CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100